Bromfenac sodium
SIGMA/SML0289 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 91714-93-1
Empirical Formula (Hill Notation): C15H11BrNNaO3
Molecular Weight: 356.15
MDL Number: MFCD03701673
Linear Formula: C15H11BrNNaO3
Product Type: Chemical
assay | ≥98% (HPLC) |
color | faintly yellow to dark yellow |
form | powder |
InChI | 1S/C15H12BrNO3.Na/c16-11- |
InChI key | HZFGMQJYAFHESD-UHFFFAOYSA |
Quality Level | 100 ![]() |
SMILES string | [Na+].Nc1c(CC([O-])=O)ccc |
solubility | H2O: ≥5 mg/mL |
storage condition | desiccated |
storage temp. | 2-8°C |
Application: | Bromfenac sodium has been used: • to study its ability to bind to melanin • in the synthesis of bromfenac indolinone standard • to analyze its permeability in porcine conjunctiva |
Biochem/physiol Actions: | Bromfenac exhibits antipyretic and prostaglandin synthetase inhibiting properties. It has therapeutic properties against the reduction of ocular pain and inflammation in postoperative cataract patients. Bromfenac acts as an effective agent against allergic conjunctivitis. It has the potential to treat acute muscle pain, osteoarthritis, and rheumatoid arthritis. |
Biochem/physiol Actions: | Bromfenac is a nonsteroidal anti inflammatory drug (NSAID) that inhibits both COX1 and COX2. It is used as an opthalmic analgesic. |
Packaging: | 10, 50 mg in glass bottle |
Symbol | ![]() |
Signal word | Warning |
Hazard statements | H400 |
Precautionary statements | P273 |
Hazard Codes | N |
Risk Statements | 50 |
Safety Statements | 61 |
RIDADR | UN 3077 9 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |